Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.
Beglyarova N, Banina E, Zhou Y, Mukhamadeeva R, Andrianov G, Bobrov E, Lysenko E, Skobeleva N, Gabitova L, Restifo D, Pressman M, Serebriiskii IG, Hoffman JP, Paz K, Behrens D, Khazak V, Jablonski SA, Golemis EA, Weiner LM, Astsaturov I.
Beglyarova N, et al. Among authors: golemis ea.
Clin Cancer Res. 2016 Dec 15;22(24):6153-6163. doi: 10.1158/1078-0432.CCR-16-0149. Epub 2016 Jul 6.
Clin Cancer Res. 2016.
PMID: 27384421
Free PMC article.